Cargando…
Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis
BACKGROUND: Metformin is a first-line oral agent used in the treatment of type 2 diabetes, but glycaemic response to this drug is highly variable. Understanding the genetic contribution to metformin response might increase the possibility of personalising metformin treatment. We aimed to establish t...
Autores principales: | Zhou, Kaixin, Donnelly, Louise, Yang, Jian, Li, Miaoxin, Deshmukh, Harshal, Van Zuydam, Natalie, Ahlqvist, Emma, Spencer, Chris C, Groop, Leif, Morris, Andrew D, Colhoun, Helen M, Sham, Pak C, McCarthy, Mark I, Palmer, Colin N A, Pearson, Ewan R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Lancet, Diabetes & Endocrinology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038749/ https://www.ncbi.nlm.nih.gov/pubmed/24731673 http://dx.doi.org/10.1016/S2213-8587(14)70050-6 |
Ejemplares similares
-
Rates of glycaemic deterioration in a real-world population with type 2 diabetes
por: Donnelly, Louise A., et al.
Publicado: (2017) -
Estimating heritability of glycaemic response to metformin using nationwide electronic health records and population-sized pedigree
por: Kalka, Iris N., et al.
Publicado: (2021) -
Reduced-Function SLC22A1 Polymorphisms Encoding Organic Cation Transporter 1 and Glycemic Response to Metformin: A GoDARTS Study
por: Zhou, Kaixin, et al.
Publicado: (2009) -
Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study
por: Connelly, Paul J., et al.
Publicado: (2017) -
A Unifying Framework for Evaluating the Predictive Power of Genetic Variants Based on the Level of Heritability Explained
por: So, Hon-Cheong, et al.
Publicado: (2010)